Literature DB >> 3035560

Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases.

M J Nicklin, H G Kräusslich, H Toyoda, J J Dunn, E Wimmer.   

Abstract

Plasmids have been constructed to generate substrates for the study of proteinases 2A and 3C of poliovirus. They contain the P1 (capsomer precursor) region of the poliovirus genome or P1 and part of P2 (a nonstructural precursor), which can be transcribed and translated in vitro. A transcript containing the entire 5' nontranslated region and the P1 region of the viral RNA gave poor translation in a reticulocyte translation system. Truncation of the 5' nontranslated region to its 3'-most segment gave acceptably good yields of radiolabeled P1. P1 was specifically processed to yield capsomer proteins by enzymes supplied in a postmitochondrial supernatant from poliovirus-infected cells. Thus, proteinase 3C can be supplied exogenously (in trans) and effect processing. This system may be used to provide P1 for the assay of proteinase 3C. Precursors that lacked either the 1A or 1D regions were poor substrates for proteinase 3C--observations that demonstrated a stringent structural requirement in processing by 3C. The translation product of a transcript encoding P1 and part of P2 was rapidly cleaved at the P1-P2 site in the absence of infected-cell extract. A transcript that contained a mutated 2A region gave a stable P1-P2 precursor that could be processed specifically by exogenous proteinase from infected-cell fractions. Processing of P1 appeared to require cleavage of the P1-P2 bond. These results support our previous data that 2A is the second polioviral proteinase and also provides a means of assaying proteinase 2A in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035560      PMCID: PMC305009          DOI: 10.1073/pnas.84.12.4002

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash.

Authors:  B A Brown; E Ehrenfeld
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

2.  Translation of poliovirus RNA in vitro: detection of two different initiation sites.

Authors:  M L Celma; E Ehrenfeld
Journal:  J Mol Biol       Date:  1975-11-15       Impact factor: 5.469

3.  Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme.

Authors:  H R Pelham
Journal:  Eur J Biochem       Date:  1978-04-17

4.  In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase.

Authors:  M F Ypma-Wong; B L Semler
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

5.  Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukaryotic messenger RNA.

Authors:  R J Jackson; T Hunt
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Primary structure, gene organization and polypeptide expression of poliovirus RNA.

Authors:  N Kitamura; B L Semler; P G Rothberg; G R Larsen; C J Adler; A J Dorner; E A Emini; R Hanecak; J J Lee; S van der Werf; C W Anderson; E Wimmer
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

7.  Identification of the initiation site of poliovirus polyprotein synthesis.

Authors:  A J Dorner; L F Dorner; G R Larsen; E Wimmer; C W Anderson
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

8.  Protein processing map of poliovirus.

Authors:  M A Pallansch; O M Kew; B L Semler; D R Omilianowski; C W Anderson; E Wimmer; R R Rueckert
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

9.  Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.

Authors:  D Etchison; S C Milburn; I Edery; N Sonenberg; J W Hershey
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

10.  Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs.

Authors:  R Hanecak; B L Semler; C W Anderson; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

View more
  59 in total

1.  Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Authors:  Sung Hoon Back; Yoon Ki Kim; Woo Jae Kim; Sungchan Cho; Hoe Rang Oh; Jung-Eun Kim; Sung Key Jang
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.

Authors:  K S Harris; S R Reddigari; M J Nicklin; T Hämmerle; E Wimmer
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.

Authors:  C U Hellen; M Fäcke; H G Kräusslich; C K Lee; E Wimmer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein.

Authors:  T V Pestova; C U Hellen; E Wimmer
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity.

Authors:  S F Yu; P Benton; M Bovee; J Sessions; R E Lloyd
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

6.  Mutational analysis of the encephalomyocarditis virus primary cleavage.

Authors:  H Hahn; A C Palmenberg
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

7.  Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F.

Authors:  E E Wyckoff; J W Hershey; E Ehrenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.

Authors:  D C Porter; L R Melsen; R W Compans; C D Morrow
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage.

Authors:  K Shiroki; T Isoyama; S Kuge; T Ishii; S Ohmi; S Hata; K Suzuki; Y Takasaki; A Nomoto
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.